Breaking News, Financial News

Financial Report: AMRI

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI 2Q Revenues: $45.6 million (-12%) 2Q Loss: $353,000* (earnings were $7.3 million in 2Q2005) YTD Revenues: $88.9 million (-12%) YTD Earnings: $1.5 million (earnings were $12.9 million YTD2005) Comments: Revenue for Discovery Services in the second quarter was $9.4 million, up 48%. Revenue from Development and Small Scale Manufacturing in the quarter was $8.2 million, up 17%. Large Scale Manufacturing revenues were $20.8 million, down 8%. Royalties from Allegra were dow...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters